Pay in 4 interest-free payments of $6.14 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Effect of glucagon-like peptide-1 receptor agonists on renal function: a meta-analysis of randomized controlled trials
The disparities in access to GLP-1 products are compounded by geographic and social determinants of health
The SURMOUNT-1 trial showed participants on 15 mg tirzepatide lost an average of 22.5% of body weight over 72 weeks
Pennsylvanias Medicaid spending for GLP-1s like Ozempic, Wegovy, and Zepbound exploded to an estimated $1.3 billion last year from $233 million in 2022, the year before Medicaid started covering the drugs for obesity
Among the study population, 336,655 patients with Type 2 diabetes received GLP-1RAs and 2,203,082 patients did not undergo treatment with GLP-1RAs
Dietary and endogenous enzymatic and nonenzymatic antioxidants counteract the damaging effects of free radicals by various mechanisms, such as electron donation, catalytic removal, or binding radicals and/or gene expression regulation
